Toxic Peptides from the Mexican Scorpion Centruroides villegasi: Chemical Structure and Evaluation of Recognition by Human Single-Chain Antibodies
Toxins · 2024
DOI: 10.3390/toxins16070301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxins, 2024. Verfasst von Lidia Riaño-Umbarila und 6 weiteren Autor:innen. Beteiligte Einrichtung: Investigadora por México, CONAHCYT, Mexico City 03940, Mexico. Hauptthemen laut MEDLINE: Scorpions, Scorpion Venoms, Peptides, Single-Chain Antibodies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Humanidades, Ciencias y Tecnologia de Mexico, Direccion General de Asuntos del Personal Academicos of National Autonomous University of Mexico, CONAHCYT (Consejo Nacional de Humanidades Ciencias y Tecnologías) of Mexico.
Abstract (Originalsprache)
Alternative recombinant sources of antivenoms have been successfully generated. The application of such strategies requires the characterization of the venoms for the development of specific neutralizing molecules against the toxic components. Five toxic peptides to mammals from the Mexican scorpion Centruroides villegasi were isolated by chromatographic procedures by means of gel filtration on Sephadex G-50, followed by ion-exchange columns on carboxy-methyl-cellulose (CMC) resins and finally purified by high-performance chromatography (HPLC) columns. Their primary structures were determined by Edman degradation. They contain 66 amino acids and are maintained well packed by four disulfide bridges, with molecular mass from 7511.3 to 7750.1 Da. They are all relatively toxic and deadly to mice and show high sequence identity with known peptides that are specific modifiers of the gating mechanisms of Na+ ion channels of type beta-toxin (β-ScTx). They were named Cv1 to Cv5 and used to test their recognition by single-chain variable fragments (scFv) of antibodies, using surface plasmon resonance. Three different scFvs generated in our laboratory (10FG2, HV, LR) were tested for recognizing the various new peptides described here, paving the way for the development of a novel type of scorpion antivenom.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Investigadora por México, CONAHCYT, Mexico City 03940, Mexico.
- Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca 62210, Mexico.
ORCID-Profile: Lidia Riaño-Umbarila, Gustavo Delgado-Prudencio, Lourival D Possani
Förderung
- Consejo Nacional de Humanidades, Ciencias y Tecnologia de Mexico
- Direccion General de Asuntos del Personal Academicos of National Autonomous University of Mexico
- CONAHCYT (Consejo Nacional de Humanidades Ciencias y Tecnologías) of Mexico
- Direccion General de Asuntos del Personal Academico of the National Autonomous University of Mexico
Zitieren
APA
Riaño-Umbarila, L., Olamendi-Portugal, T., Romero-Moreno, J. A., Delgado-Prudencio, G., Zamudio, F. Z., Becerril, B., & Possani, L. D. (2024). Toxic Peptides from the Mexican Scorpion Centruroides villegasi: Chemical Structure and Evaluation of Recognition by Human Single-Chain Antibodies. Toxins. https://doi.org/10.3390/toxins16070301
Vancouver
Riaño-Umbarila L, Olamendi-Portugal T, Romero-Moreno JA, Delgado-Prudencio G, Zamudio FZ, Becerril B, et al. Toxic Peptides from the Mexican Scorpion Centruroides villegasi: Chemical Structure and Evaluation of Recognition by Human Single-Chain Antibodies. Toxins. 2024. doi:10.3390/toxins16070301
BibTeX
@article{RiaoUmbarila2024,
author = {Riaño-Umbarila, Lidia and Olamendi-Portugal, Timoteo and Romero-Moreno, José Alberto and Delgado-Prudencio, Gustavo and Zamudio, Fernando Z and Becerril, Baltazar and Possani, Lourival D},
title = {Toxic Peptides from the Mexican Scorpion Centruroides villegasi: Chemical Structure and Evaluation of Recognition by Human Single-Chain Antibodies},
journal = {Toxins},
year = {2024},
doi = {10.3390/toxins16070301}
}
EUVIMED